1. Home
  2. CASH vs HCM Comparison

CASH vs HCM Comparison

Compare CASH & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$91.14

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$11.54

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
HCM
Founded
1954
2000
Country
United States
Hong Kong
Employees
N/A
1796
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CASH
HCM
Price
$91.14
$11.54
Analyst Decision
Buy
Sell
Analyst Count
2
1
Target Price
$107.50
$13.75
AVG Volume (30 Days)
195.0K
43.0K
Earning Date
04-22-2026
03-05-2026
Dividend Yield
0.23%
N/A
EPS Growth
18.88
N/A
EPS
4.89
N/A
Revenue
$839,894,000.00
N/A
Revenue This Year
$7.56
$20.60
Revenue Next Year
$6.02
$15.62
P/E Ratio
$18.56
$5.49
Revenue Growth
11.29
N/A
52 Week Low
$65.93
$9.77
52 Week High
$101.26
$18.17

Technical Indicators

Market Signals
Indicator
CASH
HCM
Relative Strength Index (RSI) 57.99 57.06
Support Level $86.45 $10.83
Resistance Level $94.61 $11.80
Average True Range (ATR) 2.49 0.23
MACD 0.04 0.05
Stochastic Oscillator 82.42 88.89

Price Performance

Historical Comparison
CASH
HCM

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: